Page 143 - Merck Sharp News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation. OSE Immunotherapeutics and ARCAGY - GINECO Announce Initiation of a Randomized Phase 2 Clinical ... OSE ImmunotherapeuticsMarch 15, 2021 GMT This clinical trial will be sponsored and conducted by the French oncology cooperative group ARCAGY-GINECO and supported by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, and OSE Immunotherapeutics. The study will explore Ted...

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

DUBLIN, March 11, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that nemvaleukin alfa ("nemvaleukin", formerly referred to as ALKS 4230), the company's investigational engineered

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Surface Oncology to Collaborate with Merck on Immuno-Oncology Study Evaluating SRF388, ... Surface Oncology, Inc.March 9, 2021 GMT CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWIRE) -- Surface Oncology  (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced today it has entered into a clinical trial collabor...

Eisai to Present Investigational Data from Oncology Pipeline at the Society of Gynecologic Oncology (SGO) 2021 Annual Meeting on Womens Cancer Pivotal Data on KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Versus Chemotherapy in Patients with Advanced Endometrial Cancer to be Presented During Plenary Session Additional Plenary Session to Include Investigational Data on Farletuzumab Combination with Carboplatin in Patients with Low CA125 Platinum-Sensitive Ovarian Cancer News provided by...

ADVERTISEMENT ADVERTISEMENT Merck Cant Escape Union OT Back Pay Bid In Arbitration Row Law360 (March 8, 2021, 7:22 PM EST) -- A Virginia federal court said on Monday that pharmaceutical giant Merck Sharp & Dohme Corp. must face a labor unions suit alleging that a worker was owed back pay for overtime in a job he bid for and an arbitrator found he was unfairly denied under the companys collective bargaining agreement. U.S. District Judge Elizabeth K. Dillon found that Merck could not escape an...

Dracen Announces Clinical Collaboration with Merck Share Article Dracen will develop sirpiglenastat (DRP-104) in combination with KEYTRUDA® in selected patients with Non-Small Cell Lung Cancer NEW YORK (PRWEB) March 08, 2021 Dracen Pharmaceuticals, Inc. (Dracen) announced today that it has entered into a clinical trial and supply agreement with Merck, known as MSD outside the United States and Canada, to evaluate the safety and e...

To embed, copy and paste the code into your website or blog: On February 11, 2021, Amarin Pharma, Inc. (“Amarin”) filed a petition for a writ of certiorari with the Supreme Court seeking reversal of the Federal Circuit’s decision to affirm a finding that Amarin’s patents are invalid as obvious under 35 U.S.C. § 103. 1 According to Amarin, the district court erred in its analysis because it considered evidence of objective indicia of nonobviousness only after deciding Amarin’s patents...

C R Bard Inc.: Remark: Transferring Case To The Eastern District Of Pennsylvania Via Electronic Transfer. This Is A Text Entry Only. There Is No Pdf Document Associated With This Entry. (map) [transferred From Arizona On 2/25/2021.] Weekly Newsletter Sign up × By signing up you agree to receive email newsletters or alerts from Pennsylvania Record. You can unsubscribe at any time. Protected by Google ReCAPTCHA. Case Transferred In From District Of Arizona; Case Number 2:17-cv-03568. Ori...

(1) LAS VEGAS, March 4, 2021 /PRNewswire/ -- Rare cancers account for approximately 22% of all the diagnosed cancer cases. The US National Cancer Institute defines rare cancers as those with an incidence of less than 15 cases per 100?000 per year. However, these cases are not confined to one or the other particular geography, but are disproportionately spread across the world. Many rare human cancers are not curable, and have limited number of treatment options. Rare cancers are more difficult ...